Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |